Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
THR-β agonist 3
Cat. No.:
OB0425LY-139
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
THR-β agonist 3 is a potent THR-β receptor agonist with good selectivity and pharmacokinetic properties. This compound promotes fat metabolism by enhancing the action of thyroid hormones.
Synonyms:
2656400-84-7; 4-[(1R)-5-[[(4S)-4-(3-chlorophenyl)-2-oxo-1,3,2|E5-dioxaphosphinan-2-yl]methoxy]-7-methyl-2,3-dihydro-1H-inden-1-yl]-2-propan-2-ylphenol
CAS No.:
2656400-84-7
Compound CID:
156555479
Formula:
C29H32ClO5P
Formula Weight:
526.99
Specification
Target:
Thyroid hormone receptor
Pathway:
Vitamin D related/Nuclear receptor
Storage:
Storage at -20°C.
Applications:
THR-β agonist 3 is indicated for obesity research as well as for the improvement of metabolism-related diseases such as type II diabetes.
